# Sumitomo Dainippon Pharma Co., Ltd. – FDA Inspection, Apr 16, 2019

Source: https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/7a4e397a-ac18-4bee-996b-e502e1b4dad2
Source feed: FDA_Inspections

> FDA inspection 1088923 of Sumitomo Dainippon Pharma Co., Ltd., April 16, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1088923
- Company Name: Sumitomo Dainippon Pharma Co., Ltd.
- Inspection Date: 2019-04-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1276963 - 2025-07-11](https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/959cb516-78a7-4b4f-96f4-d510481d7ed0)
- [FDA Inspection 1003840 - 2017-02-17](https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/5bae5b31-f273-4048-9552-f3d2683edd30)
- FDA Inspection 895955 - 2014-09-12
- FDA Inspection 797370 - 2012-02-24
- FDA Inspection 676813 - 2010-07-30

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/linda-f-murphy/a8b9737f-d5f4-4a36-8684-2fb050d008f2)
- [FDA Associated Person](https://www.keypedia.com/people/zhongren-wu/416f09a6-f225-4d23-a305-34f96a5c78f0)

Company: https://www.keypedia.com/companies/sumitomo-dainippon-pharma-co-ltd/a14dd605-ff5f-4e7a-a71b-73f6eb72a9c6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c